本页仅为文字内容,不可回答。

SMO-2020-4070康方AK104-207肺癌 CUSTOMER FEEDBACK SURVEY

Drug Management Drug Re-order
Unsatisfactory
Acceptable
Satisfactory
Very Satisfactory
N/A
Drug Accountability
Unsatisfactory
Acceptable
Satisfactory
Very Satisfactory
N/A
Laboratories Sample collection handle/storage/transmittal per protocol
Unsatisfactory
Acceptable
Satisfactory
Very Satisfactory
N/A
Laboratory kits
Unsatisfactory
Acceptable
Satisfactory
Very Satisfactory
N/A
Overall evaluation:If 100 is full score, please give CRC an estimated score for the past 3 monthsfor this study:
    ____________